Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Equity Ratio (2017 - 2025)

Historic Equity Ratio for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to 0.45.

  • Arcus Biosciences' Equity Ratio rose 299.65% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year increase of 299.65%. This contributed to the annual value of 0.42 for FY2024, which is 4.23% down from last year.
  • Arcus Biosciences' Equity Ratio amounted to 0.45 in Q3 2025, which was up 299.65% from 0.51 recorded in Q2 2025.
  • Arcus Biosciences' 5-year Equity Ratio high stood at 0.71 for Q1 2021, and its period low was 0.42 during Q4 2024.
  • In the last 5 years, Arcus Biosciences' Equity Ratio had a median value of 0.51 in 2022 and averaged 0.51.
  • In the last 5 years, Arcus Biosciences' Equity Ratio tumbled by 2736.35% in 2022 and then soared by 1406.07% in 2024.
  • Quarter analysis of 5 years shows Arcus Biosciences' Equity Ratio stood at 0.53 in 2021, then decreased by 4.45% to 0.51 in 2022, then dropped by 16.52% to 0.42 in 2023, then dropped by 0.04% to 0.42 in 2024, then rose by 6.14% to 0.45 in 2025.
  • Its Equity Ratio stands at 0.45 for Q3 2025, versus 0.51 for Q2 2025 and 0.46 for Q1 2025.